Understanding PLK4 in Melanoma Treatment
Functional and Therapeutic Significance of PLK4 in Melanoma
This project looks for new ways to treat melanoma by focusing on a specific protein called PLK4.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of Wisconsin-Madison NIH-funded |
| Lab location | 1 site (Madison, United States) |
| Project ID | NIH-11103380 on NIH RePORTER |
What this research studies
Melanoma is a serious skin cancer, and current treatments often face resistance, meaning they stop working for some patients. This project explores a protein called PLK4, which may play a key role in how melanoma develops and progresses. Researchers are working to understand how PLK4 interacts with other pathways in melanoma cells. The goal is to discover if targeting PLK4 could lead to new, more effective drug treatments for patients, especially those who no longer respond to existing therapies.
Who could benefit from this research
Good fit: Patients with melanoma, particularly those whose tumors have specific genetic mutations like BRAFV600E or have developed resistance to current therapies, could potentially benefit from future treatments developed from this research.
Not a fit: Patients without melanoma or those whose cancer does not involve the PLK4 pathway may not directly benefit from this specific research.
Why it matters
Potential benefit: If successful, this work could lead to new drug therapies for melanoma patients, especially those who develop resistance to existing treatments.
How similar studies have performed: Limited recent studies suggest PLK4 could be a potential drug target for certain cancers, indicating this approach builds on emerging evidence.
Where this research is happening
Madison, United States
- University of Wisconsin-Madison — Madison, United States (Active)
Researchers
- Principal investigator: Ahmad, Nihal — University of Wisconsin-Madison
- Study coordinator: Ahmad, Nihal
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.